Related Experiment Video
Updated: Jul 3, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
[Stem cell therapy in acute myocardial infarction]
M Brehm1, E Darrelmann, B E Strauer
1Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine Universität, Moorenstrasse 5, Düsseldorf, Germany. brehm@med.uni-duesseldorf.de
Insights
Stem cell therapy shows promise for treating heart conditions like myocardial infarction. Clinical trials confirm that stem cell injections improve outcomes for patients with reduced cardiac function after heart attacks.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Context:
- Cardiovascular diseases, including acute myocardial infarction and chronic coronary artery disease, pose significant health challenges.
- Stem cell research offers novel therapeutic strategies for cardiac repair and regeneration.
- Current research focuses on various delivery methods for stem cells to damaged heart tissue.
Purpose:
- To investigate the efficacy of stem cell therapy in treating cardiovascular diseases.
- To evaluate different stem cell delivery routes, including intracoronary, intravenous, transendocardial, and intramyocardial injections.
- To assess the potential of stem cells for myocardial regeneration and functional recovery.
Summary:
- Adult autologous stem cells and circulating progenitor cells are being clinically investigated for myocardial regeneration.
- Multiple delivery methods are being explored to regenerate damaged heart muscle following myocardial infarction or chronic coronary artery disease.
- Clinical studies and meta-analyses indicate a positive therapeutic impact of intracoronary stem cell application on mortality and morbidity in post-myocardial infarction patients with impaired cardiac function.
Impact:
- Stem cell therapy represents a promising approach for preventing cardiac failure and improving patient outcomes.
- Successful myocardial regeneration through stem cell injection could revolutionize the treatment of heart disease.
- Further research and clinical trials are essential to optimize stem cell delivery and application for cardiovascular regeneration.
Abstract:
Therapeutic successes in the area of stem cell research have opened up many new avenues for treating cardiovascular diseases, especially with respect to the prevention of the development of cardiac failure due to acute myocardial infarction or chronic coronary artery disease. Currently, the delivery of bone marrow-derived stem cells and circulating progenitor cells via the coronary artery, intravenous, the left ventricle (transendocardial) as well as directly into the heart muscle during cardiac bypass surgery (intramyocardial) is being investigated intensively for the treatment of acute myocardial infarction and chronic coronary artery disease. All application modes pursue the same objective of regenerating damaged myocardium. In clinical studies, the concept of myocardial regeneration by injection of adult autologous stem cells or circulating progenitor cells has been transferred. In the majority of controlled and randomised trials as well as in several meta-analysis the therapeutic impact of intracoronary stem cell application in myocardial infarction is affirmed by a beneficial effect of stem cells or progenitor cells on mortality and morbidity in patients with reduced cardiac function after acute myocardial infarction.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction